EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS

QR code

EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS

Aim. To study the effect of sacubitril/valsartan compared with valsartan on natriuresis, diuresis, blood pressure (BP) and the level of biomarkers in hypertensive patients.Material and methods. Hypertensive patients (n=16) received sacubitril/valsartan 400 mg QD or valsartan 320 mg QD for 7 days in...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteurs:	Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina
Formaat:	Artikel
Taal:	Engels
Gepubliceerd in:	Столичная издательская компания 2017-07-01
Reeks:	Рациональная фармакотерапия в кардиологии
Onderwerpen:	sacubitril/valsartan natriuresis diuresis blood pressure cyclic guanosine monophosphate brain natriuretic peptide
Online toegang:	https://www.rpcardio.online/jour/article/view/1488
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

BOLD MRI to Evaluate the Effects of Sacubitril/Valsartan on Renal Protection in Type 2 Diabetics
door: Zhai L, et al.
Gepubliceerd in: (2025-05-01)

Early diuretic response and outcome prediction in ambulatory worsening heart failure: Natriuresis versus diuresis
door: M. Cobo Marcos, et al.
Gepubliceerd in: (2025-08-01)

EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
door: Zh. D. Kobalava, et al.
Gepubliceerd in: (2018-05-01)

Potential of valsartan+sacubitril therapy in hypertensive heart disease
door: A. G. Ovchinnikov, et al.
Gepubliceerd in: (2021-08-01)

Effects of Sacubitril/Valsartan on Blood Pressure and Proteinuria in Hypertensive Patients With Chronic Kidney Disease
door: Maki Murakoshi, et al.
Gepubliceerd in: (2025-07-01)

Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study
door: K. V. Charaya, et al.
Gepubliceerd in: (2023-01-01)

Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic Study
door: Daina Martínez‐Falguera, et al.
Gepubliceerd in: (2025-06-01)

Natriuretic peptides: new challenges — new solutions
door: O. M. Drapkina, et al.
Gepubliceerd in: (2021-11-01)

Redefining Thyroid Hormone Sensitivity in Diabetic Kidney Disease: A Paradigm Shift in Pathophysiological Understanding [Letter]
door: Gao Y, et al.
Gepubliceerd in: (2025-05-01)

Right ventricular strain predicts outcome in patients receiving sacubitril/valsartan: A sub‐analysis of DISCOVER‐ARNI
door: Maria Concetta Pastore, et al.
Gepubliceerd in: (2025-08-01)

Tolerability for older, persistence for younger: a real-world evidence on sacubitril/valsartan in an Asian heart failure cohort across age
door: Po-Kai Chan, et al.
Gepubliceerd in: (2025-07-01)

Geum japonicum Thunb. exhibits anti-platelet activity via the regulation of cyclic guanosine monophosphate
door: Yuan Yee Lee, et al.
Gepubliceerd in: (2025-06-01)

Effectiveness of neoton in patients with heart failure receiving sacubitril/valsartan. Sub-analysis of the BYHEART study
door: S. N. Tereshchenko, et al.
Gepubliceerd in: (2024-06-01)

Experience of sacubitril/valsartan therapy in hypertension
door: E. V. Oshchepkova
Gepubliceerd in: (2023-09-01)

Сost-effectiveness of preventing cardiovascular death and achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health Development" when using valsartan+sacubitril, dapagliflozin and empagliflozin in patients with heart failure with reduced ejection fraction
door: M. V. Zhuravleva, et al.
Gepubliceerd in: (2023-04-01)

Increased natriuretic peptides not associated with heart failure
door: A. M. Chaulin, et al.
Gepubliceerd in: (2021-01-01)

Death of Leukemia Cells and Platelets Induced by 3,3′-Dihydroxy-4,5-Dimethoxybibenzyl Is Mediated by p38 Mitogen-Activated Protein Kinase Pathway
door: Natalia Rukoyatkina, et al.
Gepubliceerd in: (2025-07-01)

Quantitative determination of cyclic guanosine monoposphate (c-GMP) in rat tissues using liquid chromatography and tandem mass spectrometry
door: N. S. Popov, et al.
Gepubliceerd in: (2023-11-01)

Determination of Multiple Free Nucleotides in Meat Products by High Performance Liquid Chromatography
door: JI Xiaomeng, WANG Zhen, REN Nan, LIU Mengyao, KONG Weiheng, ZHAO Wentao, WANG Jiangyue, LIU Xinyi, GUO Wenping
Gepubliceerd in: (2025-07-01)

COMBINED MONITORING OF DIURESIS AND BLOOD PRESSURE IN PATIENTS WITH ARTERIAL HYPERTENSION AND HEART FAILURE
door: M. P. Savenkov, et al.
Gepubliceerd in: (2009-12-01)

The Study of the Fixed Dose Combination of Lisinopril with Prolonged Indopamide (FIXLINDA) with Daily Blood Pressure Monitoring and Diuresis in Hypertensive Patients
door: M. P. Savenkov, et al.
Gepubliceerd in: (2019-09-01)

Prophylactic role of omega 3 fatty acids in bisphenol F-induced sexual and erectile dysfunction is associated with penile redox homeostasis
door: Adeyemi Fatai Odetayo, et al.
Gepubliceerd in: (2025-09-01)

Heart Failure and Wide QRS: Clinical and Pharmacological Perspectives
door: Alfredo Mauriello, et al.
Gepubliceerd in: (2025-06-01)

Defining post-obstructive diuresis following posterior urethral valve ablation
door: Callum Lavoie, et al.
Gepubliceerd in: (2025-07-01)

ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION
door: V. I. Podzolkov, et al.
Gepubliceerd in: (2015-09-01)

Effects of Cyclic Adenosine Monophosphate Nanoliposomes on Growth Performance, Gut Development and Microbiota of Broilers
door: Li Chen, et al.
Gepubliceerd in: (2025-06-01)

Chronic Heart Failure in Patients with Arterial Hypertension Associated with Obstructive Sleep Apnea Syndrome: Possible Options to Pathogenetic Therapy
door: A. V. Yakovlev, et al.
Gepubliceerd in: (2021-07-01)

Cost-effectiveness of valsartan+sakubitril, dapagliflosin and empagliflosin for prevention of cardiovascular death and reducing cardiovascular mortality within the State Program "Health Development" in patients with heart failure
door: M. V. Zhuravleva, et al.
Gepubliceerd in: (2023-12-01)

Effects of fluvastatin, valsartan, and their combination on endothelial function in patients with arterial hypertension and dyslipidemia
door: T. Sh. Mirilashvili, et al.
Gepubliceerd in: (2009-08-01)

Comparative efficacy of medication and cardiac resynchronization therapy in patients with heart failure with reduced ejection fraction
door: U. A. Eyyubova
Gepubliceerd in: (2021-09-01)

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases
door: A. Ya. Panarina, et al.
Gepubliceerd in: (2024-11-01)

Association between NT‐proBNP changes and clinical outcomes in paediatric patients with heart failure: Insights from PANORAMA‐HF and PARADIGM‐HF
door: Robert Shaddy, et al.
Gepubliceerd in: (2025-08-01)

PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS
door: S. K. Zyryanov, et al.
Gepubliceerd in: (2018-05-01)

The role of CAMP-dependent signaling systems in regulation of electrical and contractile properties of smooth muscles of the ureter in hypoxia in guinea pigs
door: I. V. Kovalev, et al.
Gepubliceerd in: (2019-08-01)

Changes of natriuresis and prediction of cardiovascular events in patients with type 2 diabetes and decompensated heart failure over therapy with sodium-glucose cotransporter 2 inhibitors and standard diuretic therapy
door: O. A. Abdullaev, et al.
Gepubliceerd in: (2024-03-01)

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
door: I. N. Medvedev, et al.
Gepubliceerd in: (2007-06-01)

Vibrio cholerae Biofilm: Mechanisms, Regulating Formation and Signals of External Environment, Factoring Its Production
door: N. A. Plekhanov, et al.
Gepubliceerd in: (2019-10-01)

ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY
door: V. I. Podzolkov, et al.
Gepubliceerd in: (2016-01-01)

DISSOLUTION PROFILE STUDIES OF BCS CLASS II DRUG VALSARTAN BY BIOWAIVER PROCEDURE
door: E. R. Brigas, et al.
Gepubliceerd in: (2019-01-01)

INFLUENCE OF ANTHELMINTIC DRUGS ON ACTIVITIES OF 5'-NUCLEOTIDASE Bothriocephalus scorpii (Cestoda: Bothriocephalidae)
door: E. A. BURENINA
Gepubliceerd in: (2016-05-01)